Home
Stock
ETF
Institutional Holdings
Compound interest
Blog
Support Me
Login
Join us
Français
English
LSE
/
Healthcare
/
Medical - Pharmaceuticals
/
0R2M.L
Regeneron Pharmaceuticals, Inc.
0R2M.L
Summary
30-Y Financials
Dividend
Analyst
Peer analysis
Key metrics
Ownership / Senat
Dividend historical
Dividend payout ratio
4.18
%
Dividend split
Date
Split
